Sign In
Buy BLKB
$28.11
-2.30 (-7.56%)
At Close: Jun 03, 2026
Blackbaud, Inc. (BLKB) CEO Mike Gianoni on Q1 2022 Results - Earnings Call Transcript
01:25pm, Wednesday, 04'th May 2022
Blackbaud, Inc. (NASDAQ:BLKB ) Q1 2022 Earnings Conference Call May 4, 2022 8:00 AM ET Company Participants Steve Hufford - Director, Investor Relations Mike Gianoni - President and CEO Tony Boor - Ex
Blackbaud (BLKB) Q1 Earnings Miss Estimates
10:35pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Blackbaud (BLKB) delivered earnings and revenue surprises of -12.31% and 0.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Blackbaud (BLKB) Q1 Earnings Miss Estimates
08:19pm, Tuesday, 03'rd May 2022
Blackbaud (BLKB) delivered earnings and revenue surprises of -12.31% and 0.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Manhattan Associates (MANH) Beats Q1 Earnings and Revenue Estimates
09:45pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Manhattan Associates (MANH) delivered earnings and revenue surprises of 33.33% and 6.01%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Blackbaud Announces Date of First Quarter 2022 Financial Results
04:10pm, Tuesday, 19'th Apr 2022
CHARLESTON, S.C. , April 19, 2022 /PRNewswire/ -- Blackbaud (NASDAQ: BLKB), the world's leading cloud software company powering social good, will report its first quarter 2022 financial results
Zacks.com featured highlights Ligand Pharmaceuticals, Las Vegas Sands, CoStar Group and Blackbaud
10:26am, Friday, 01'st Apr 2022 Zacks Investment Research
Ligand Pharmaceuticals, Las Vegas Sands, CoStar Group and Blackbaud have been highlighted in this Screen of the Week article.
Don't Let These Toxic Stocks Disrupt Your Portfolio
01:03pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Ligand (LGND), Las Vegas Sands (LVS), CoStar (CSGP) and Blackbaud (BLKB) are a few toxic stocks that you should dump to avoid portfolio bleeding.
Don't Let These Toxic Stocks Disrupt Your Portfolio
10:32am, Thursday, 31'st Mar 2022
Ligand (LGND), Las Vegas Sands (LVS), CoStar (CSGP) and Blackbaud (BLKB) are a few toxic stocks that you should dump to avoid portfolio bleeding.
Blackbaud (BLKB) Now Boasts PayPal and Venmo Payment Options
01:37pm, Thursday, 24'th Mar 2022 Zacks Investment Research
Blackbaud (BLKB) noted that the integrations with PayPal and Venmo will enable social good organizations to create a safe and seamless checkout experience for registration, donations and so on.
Blackbaud (BLKB) Now Boasts PayPal and Venmo Payment Options
11:17am, Thursday, 24'th Mar 2022
Blackbaud (BLKB) noted that the integrations with PayPal and Venmo will enable social good organizations to create a safe and seamless checkout experience for registration, donations and so on.
Blackbaud (BLKB) Collaborates With Change Donation Platform
02:52pm, Friday, 11'th Mar 2022 Zacks Investment Research
Blackbaud (BLKB) partners with the Change donation platform to provide companies with "customer-facing giving experiences."
Blackbaud (BLKB) Collaborates With Change Donation Platform
11:17am, Friday, 11'th Mar 2022
Blackbaud (BLKB) partners with the Change donation platform to provide companies with "customer-facing giving experiences."
Blackbaud: A Company That Continues To Inspire Little Faith
10:24pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Blackbaud, Inc. (BLKB) CEO Michael Gianoni on Q4 2021 Results - Earnings Call Transcript
05:34pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Blackbaud (BLKB) Q4 Earnings and Revenues Beat Estimates
03:46pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
Blackbaud's (BLKB) fourth-quarter 2021 revenues benefit from increases in recurring revenues.
